Publications

5532 Results

Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive and estrogen receptor-positive breast cancer patients: A Southwest Oncology Group study

Authors
SE Rivkin;S Green;B Metch;AB Cruz;MD Abeloff;WR Jewell;JJ Costanzi;WB Farrar;JP Minton;CK Osborne
Journal / Conference
Journal of Clinical Oncology 12(10):2078-2085
Year
1994
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

Phase II trial of didemnin B (DNB) in patients (pts) with recurrent or residual malignant gliomas

Authors
SA Taylor;C Upchurch;C Schold
Journal / Conference
Annals of Oncology 5(Suppl.5)(#280)
Year
1994
Research Committee(s)
Brain
Study Number(s)
SWOG-9110

A Southwest Oncology Group phase II evaluation of fludarabine monophosphate in sarcoma.

Authors
MR Grever;J Benedetti;SP Balcerzak;SA Taylor;TP Miller;SR Dakhil
Journal / Conference
Investigational New Drugs 12:259-261
Year
1994
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8322

A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: Results of SWOG-8516 (Intergroup 0067), the national high-priority lymphoma study

Authors
RI Fisher;ER Gaynor;S Dahlberg;MM Oken;TM Grogan;EM Mize;JH Glick;CA Coltman;TP Miller
Journal / Conference
Annals of Oncology 5(Suppl.2):S91-S95
Year
1994
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8516 (INT-0067)

Extended oral etopside (E) and oral cyclophosphamide (C) for lung cancer

Authors
SM Grunberg;J Crowley;R Livingston
Journal / Conference
Lung Cancer 11(Suppl.1):121(#464)
Year
1994
Research Committee(s)
Lung
Study Number(s)
SWOG-9038, SWOG-9307

Treatment of histologically confirmed D2 prostate cancer - a comparison of bilateral orchiectomy with or without flutamide (intergroup study 0105)

Authors
ED Crawford;MA Eisenberger;B Blumenstein;DG McLeod;DJ Culkin;AJ Bueschen;IM Thompson;BA Lowe
Journal / Conference
Urology 151(5):238A(#44)
Year
1994
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Randomized trial of vitamin A versus observation as adjuvant therapy in high risk primary malignant melanoma: A Southwest Oncology Group study

Authors
FL Meyskens;PY Liu;RJ Tuthill;VK Sondak;WS Fletcher;WR Jewell;W Samlowski;SP Balcerzak;DJ Rector;RD Noyes;JJ Costanzi
Journal / Conference
Journal of Clinical Oncology 12(10):2060-2065
Year
1994
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8049

Phase II evaluation of merbarone in renal cell carcinoma

Authors
RC Flanigan;JH Saiers;M Wolf;EH Kraut;AY Smith;B Blumenstein;ED Crawford
Journal / Conference
Investigational New Drugs 12(2):147-149
Year
1994
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8929

A phaseIII randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma: A Southwest Oncology Group study

Authors
WS Dalton;JJ Crowley;SE Salmon;TM Grogan;LR Laufman;GR Weiss;JD Bonnet
Journal / Conference
Cancer 75(3):815-820
Year
1994
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8900

Phase II trial of trimetrexate in untreated advanced gastric carcinoma. A Southwest Oncology Group study.

Authors
A Hantel;C Tangen;JS Macdonald;SP Richman;RP Pugh;T Pollock
Journal / Conference
Investigational New Drugs 12:155-157
Year
1994
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8623